T
Live / Applied — Statement of use — registration review complete (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 18 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99291787
- Mark type
- Design + words
- Filed
- 18 Jul 2025
- Published for opposition
- 06 Jan 2026
- Attorney of record
- Jun Chen
Goods and services
- Class 042 — Scientific and technological services: Technical research in the field of pharmaceutical studies; Laboratory research in the field of pharmaceuticals; Research and development services of new pharmaceutical products; Pharmaceutical research in the field of immunotherapy, autoimmune diseases, nanoparticles, and nanomedicine; Medical research laboratories; Pharmaceutical products development; Research on the subject of pharmaceuticals; Drug screening for scientific research purposes; Drug discovery services; Research and development services in the field of biotechnology
Owner
- TangGene Inc., Basking Ridge, NJ, US
- TangGene Inc., Basking Ridge, NJ, US
Prosecution history
- 09 Sept 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Sept 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Sept 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Jul 2026 — USE AMENDMENT FILED
- 29 Jul 2026 — TEAS STATEMENT OF USE RECEIVED
- 03 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jan 2026 — PUBLISHED FOR OPPOSITION
- 31 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Dec 2025 — ASSIGNED TO EXAMINER
- 25 Nov 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 25 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Jul 2025 — NEW APPLICATION ENTERED